Abbas, Z. et al. 2023. FDA approves tebentafusp-tebn for unresectable or metastatic uveal melanoma. Journal of the Pakistan Medical Association. 73, 10 (Sep. 2023), 2127–2127. DOI:https://doi.org/10.47391/JPMA.9359.